Hikal Posts 30% Dividend
22 January 2008 India-based Hikal declared a 30% interim dividend at a recent board of directors meeting, according to an article on www.myiris.com.
Hikal, which provides a broad spectrum of research and development and custom manufacturing solutions in pharmaceuticals, biotechnology, agrochemicals, and specialty chemicals, supplies molecules for discovery research on a contract basis, develops non-infringing processes and scales them for commercial scale production, and undertakes method validation of new substances and custom manufacturing of intermediates and active ingredients for pharmaceutical and agrochemical companies worldwide.
Get The Newsletter Today!
